In humans, PD reportedly causes a shift in sensitivity toward negative outcomes in the PRL task, which was influenced by L-DOPA treatment (Frank et al., 2004; Cools et al., 2006), and possibly a general modest impairment in the PRL task (Grogan et al., 2017; Meder et al., 2019). This evidence concerns the gene PRL and Parkinson disease.